Home/Filings/4/0001127602-17-019148
4//SEC Filing

MERIDIAN BIOSCIENCE INC 4

Accession 0001127602-17-019148

CIK 0000794172operating

Filed

May 22, 8:00 PM ET

Accepted

May 23, 1:36 PM ET

Size

6.6 KB

Accession

0001127602-17-019148

Insider Transaction Report

Form 4
Period: 2017-05-19
Elagin Vecheslav A
Sr VP, Research & Development
Transactions
  • Award

    Stock Options (Right to Buy)

    2017-05-19+10,00010,000 total
    Exercise: $13.60Exp: 2027-05-19Common Stock (10,000 underlying)
Holdings
  • Common Stock

    (indirect: By 401(k))
    79
  • Common Stock

    52,926
Footnotes (1)
  • [F1]These options are awarded under the 2012 Stock Incentive Plan in connection with promotion to Executive Vice President, Research & Development and Chief Scientific Officer, and vest in four equal installments from the date of grant (i.e., 25% per year until fully vested on May 19, 2021).

Issuer

MERIDIAN BIOSCIENCE INC

CIK 0000794172

Entity typeoperating
IncorporatedOH

Related Parties

1
  • filerCIK 0000794172

Filing Metadata

Form type
4
Filed
May 22, 8:00 PM ET
Accepted
May 23, 1:36 PM ET
Size
6.6 KB